Compare Cadila Healthcare with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ELDER PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ELDER PHARMA CADILA HEALTHCARE/
ELDER PHARMA
 
P/E (TTM) x 29.2 -0.2 - View Chart
P/BV x 3.5 0.1 3,453.8% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 CADILA HEALTHCARE   ELDER PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
ELDER PHARMA
Jun-14
CADILA HEALTHCARE/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs432380 113.8%   
Low Rs306188 163.0%   
Sales per share (Unadj.) Rs128.6491.2 26.2%  
Earnings per share (Unadj.) Rs18.5-3.2 -582.9%  
Cash flow per share (Unadj.) Rs24.414.4 169.3%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs101.5376.5 26.9%  
Shares outstanding (eoy) m1,023.7420.54 4,984.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.90.6 496.8%   
Avg P/E ratio x19.9-89.3 -22.3%  
P/CF ratio (eoy) x15.119.7 76.8%  
Price / Book Value ratio x3.60.8 482.7%  
Dividend payout %18.90-   
Avg Mkt Cap Rs m378,1705,833 6,482.9%   
No. of employees `00012.4NA-   
Total wages/salary Rs m21,2412,179 974.8%   
Avg. sales/employee Rs Th10,585.0NM-  
Avg. wages/employee Rs Th1,707.8NM-  
Avg. net profit/employee Rs Th1,526.5NM-  
INCOME DATA
Net Sales Rs m131,65610,089 1,304.9%  
Other income Rs m2,011257 783.7%   
Total revenues Rs m133,66710,346 1,292.0%   
Gross profit Rs m29,731-792 -3,754.4%  
Depreciation Rs m5,986361 1,656.8%   
Interest Rs m1,9352,756 70.2%   
Profit before tax Rs m23,821-3,653 -652.1%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m5,303125 4,237.3%   
Profit after tax Rs m18,987-65 -29,054.3%  
Gross profit margin %22.6-7.8 -287.7%  
Effective tax rate %22.3-3.4 -649.8%   
Net profit margin %14.4-0.6 -2,226.5%  
BALANCE SHEET DATA
Current assets Rs m84,9819,240 919.7%   
Current liabilities Rs m73,4259,998 734.4%   
Net working cap to sales %8.8-7.5 -116.9%  
Current ratio x1.20.9 125.2%  
Inventory Days Days7546 160.9%  
Debtors Days Days11060 182.7%  
Net fixed assets Rs m133,49310,124 1,318.6%   
Share capital Rs m1,024206 497.8%   
"Free" reserves Rs m102,8395,582 1,842.2%   
Net worth Rs m103,8637,734 1,343.0%   
Long term debt Rs m39,4974,889 807.9%   
Total assets Rs m234,83122,882 1,026.3%  
Interest coverage x13.3-0.3 -4,091.9%   
Debt to equity ratio x0.40.6 60.2%  
Sales to assets ratio x0.60.4 127.2%   
Return on assets %8.911.8 75.8%  
Return on equity %18.3-0.8 -2,163.3%  
Return on capital %18.322.3 82.0%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m48,404307 15,787.3%   
Fx outflow Rs m11,593125 9,252.2%   
Net fx Rs m36,811181 20,303.9%   
CASH FLOW
From Operations Rs m28,82311,754 245.2%  
From Investments Rs m-57,387-561 10,238.5%  
From Financial Activity Rs m18,846-6,762 -278.7%  
Net Cashflow Rs m-7,1054,432 -160.3%  

Share Holding

Indian Promoters % 74.8 39.6 188.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 7.5 110.7%  
FIIs % 5.9 16.8 35.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 36.1 30.5%  
Shareholders   44,069 16,479 267.4%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DISHMAN PHARMA  WOCKHARDT  VENUS REMEDIES  DR. DATSONS LABS  GLENMARK PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

June WPI Inflation Data, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Tuesday, Indian share markets fell sharply, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

How We Made 10%+ Profits Overnight(Fast Profits Daily)

Jul 3, 2020

A simple trade in natural gas delivered more than 10% overnight. Here's how we did it...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 14, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS